Generic-drug makers including Momenta Pharmaceuticals Inc. In a court filing today, Momenta, Novartis AG's Sandoz and Mylan Inc. said they would suffer "immense harm" if barred from selling generic Copaxone in the U.S. after some of the drug's ... BusinessWeek, 2 days ago
Teva's Generic Copaxone Rivals Asked to Respond on Delay - Bloomberg, 1 week ago
2 images for "sandoz inc"
PRINCETON, N.J. Sandoz Inc. has rolled out lansoprazole capsules, amoxicillin capsules and clarithromycin tablets, a generic version of the combination medicine Prevpac from Takeda Pharmaceuticals. The Novartis subsidiary said Thursday that it's ...Chain Drug Review, 2 weeks ago Sandoz launches H. pylori infection therapy in US Individual.com, 2 weeks ago
Teva Pharmaceutical Industries Ltd, Mylan Inc. , Actavis plc and Sandoz For the full text of this story please click the following link: http://www.moodys.com/page/viewresearchdoc.aspx-docid=PR_295755&WT.mc_id=NLTITLE_YYYYMMDD_PR_295755 ...Yahoo! Finance, 3 weeks ago Moody's: M&A among generic drug makers raises risk for investors Capital Market, 2 weeks ago
| BioSpace, 1 week ago
Novartis : Names New Alcon, Sandoz Division Heads
4 Traders, 1 week ago
Novartis Names New Alcon, Sandoz Division Heads ...
ADVFN UK, 1 week ago
More from: ADVFN India, ADVFN UK...and 3 other sources
FEATURED COMPANIES 3 SBio Inc. Bioton Dr.Reddy's Labs (DRL) Hospira Ratiopharm GmbH Sandoz GmbH MORE The global biosimilars market is at a crucial turning point, as ...Research and Markets, 1 month ago Global EPO Biosimilars Market Outlook 2018 Research and Markets, 1 month ago World Market for Biosimilars to 2017: EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others Individual.com, 13 hours ago Global Biosimilars (Recombinant Non-Glycosylated & Recombinant Glycosylated Proteins & Recombinant Peptides) Market 2013-2018 Individual.com, 2 days ago
Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. Sandoz Inc. case (Supreme Court docket number 13-854). The sole issue on appeal is encapsulated by the question presented: QUESTION PRESENTED: ...JD Supra, 2 weeks ago The Supreme Court - April 2, 2014 Lexology, 5 days ago UPDATE 1-Teva asks U.S. Supreme court to stay ruling in Copaxone case CNBC, 1 week ago Teva asks Supreme court to stay ruling in Copaxone case Chicago Tribune, 1 week ago
WASHINGTON, April 7 (Reuters) - Teva Pharmaceutical Industries Inc on Monday asked the U.S. Supreme Court to prevent an appeals court ruling from going into effect while the justices consider the company's appeal in a patent fight over top-selling ...CNBC, 1 week ago
More from: , Sharenet...and 2 other sources
Atossa Genetics, Inc., a developer of breast health products, has appointed Ben Chen to the newly created position of senior vice president, or SVP, of global regulatory affairs and quality assurance. Mr Chen will oversee all facets of Atossa's ...Individual.com, 1 week ago ATOSSA GENETICS : Ben R. Chen Joins Atossa Genetics as Senior Vice President of Global Regulatory Affairs and Quality Assurance 4 Traders, 2 weeks ago Ben R. Chen Joins Atossa Genetics as Senior Vice President of Global Regulatory Affairs and Quality Assurance Freshnews.com, 2 weeks ago
More from: , Scottrade...and 5 other sources
Ico Therapeutics, Inc. (ICOTF: OTCQX International) | Immune CEO Announces New Operational Leadership Team
(GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) announced today the addition of two new senior members to its management team. Elliot Goldstein, MD, joins as Chief Medical Officer.Dr. Goldsteinbrings a unique track ...Pink Sheets, 2 weeks ago Immune Pharmaceuticals Inc. (IMNP: OTCQX U.S.) | IMMUNE CEO ANNOUNCES NEW OPERATIONAL LEADERSHIP TEAM Elliott Goldstein, MD, joins as Chief Medical Officer, Eugene Williams joins as Chief Operating Officer Pink Sheets, 2 weeks ago Immune CEO Announces New Operational Leadership Team Reuters, 2 weeks ago Immune Pharmaceuticals, Inc. CEO Announces New Operational Leadership Team BioSpace, 2 weeks ago
By a News Reporter-Staff News Editor at Biotech Week -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced the appointment of John Sedor as a non-executive Director and Chairman of the Compensation ...HispanicBusiness.com, 4 weeks ago PERNIX THERAPEUTICS HOLDINGS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers TMC Net, 4 weeks ago PERNIX THERAPEUTICS : Appoints John Sedor to Its Board of Directors 4 Traders, 1 month ago Patent Issued for Cyclosporin Analogues 4 Traders, 6 days ago
on your WebpageAdd Widget >Get your members hooked!